Prognostic significance of HSP-27 in astrocytic brain tumors: An immunohistochemical study

Anticancer Research

Volumn 17, Issue 4 A, 1997, Pages 2677-2682

  Assimakopoulou, Martha ^a   Sotiropoulou Bonikou, Georgia ^a   Maraziotis, Theodoros ^a   Varakis, Ioannis ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Brain astrocytic tumors; Heat shock protein 27; Immunohistochemistry

Indexed keywords

ANTINEOPLASTIC AGENT; FORMALDEHYDE; HEAT SHOCK PROTEIN; MONOCLONAL ANTIBODY; PARAFFIN; PEROXIDASE; STREPTAVIDIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; ASTROCYTE; ASTROCYTOMA; BLOOD VESSEL; BRAIN CANCER; CANCER GRADING; CANCER RECURRENCE; CELL PROLIFERATION; CHILD; CYTOPLASM; DIAGNOSTIC VALUE; ENDOTHELIUM CELL; FEMALE; GLIOBLASTOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; STAINING; TUMOR BIOPSY; TUMOR DIFFERENTIATION;

ADULT; ASTROCYTES; ASTROCYTOMA; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0030804719     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Adams DJ, Hajj H, Edwards DP, Bjercke RJ, McGuire WL: Detection of a Mr 24,000 estrogen-regulated protein in human breast cancer by monoclonal antibodies. Cancer Res 43: 4297-4301, 1983.
2. Adams DJ, McGuire WL: Quantitative enzyme linked immunosorbent assay for the estrogen-regulated Mr 24,000 protein in human dreast tumors. Correlation with estrogen and progesterone receptors. Cancer Res 45: 2445-2449, 1985.
3. Burger PC, Vogel S, Green SB, Strike TA: Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56: 1106-1111, 1985.
4. Chretien P, Landry J: Enhanced constitutive expression of the 27-kDa heat shock proteins in heat-resistant variants from Chinese hamster cells. J Cell Physiol 137: 157-166, 1988.
5. Ciocca DR, Adams DJ, Edwards DP, Bjercke RJ, McGuire WL: Distribution of an estrogen-induced protein with a molecular weight of 24,000 in normal and malignant human tissues and cells. Cancer Res 43: 1204-1210, 1983.
6. Ciocca DR, Fuqua SAW, Lock-Lim S, Toft DO, Welch WJ: Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res 52: 3648-3654, 1992.
7. Ciocca DR, Luque EH: Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer. Breast Cancer Res Treat 20(1): 33-42, 1991.
8. Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SAW: Biological and clinical implications of heat shock protein 27000 (HSP27): a review. J Natl Cancer Inst 85: 1558-1570, 1993.
9. Ciocca DR, Puy LA, Fasoli LC: Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix. Cancer Res 49: 4298-4304, 1989.
10. Courtney SP, Williams S, Mansel RE: Evaluation of immunohistochemical staining of breast tissue by an oestrogen-regulated protein, 24k according to epidemiological and radiological breast cancer risk criteria. Cancer Lett 54: 75-80, 1990.
11. Harrison JD, Jones JA, Ellis IO et al: Oestrogen receptor D5 antibody is an independent negative prognostic factor in gastric cancer. Br J Surg 78: 334-336, 1991.
12. Hightower LE: Heat shock, stress proteins, chaperones, and proteotoxicity. Cell 66: 191-197, 1991.
13. Hitotsumatsu T, Iwaki T, Fukui M, Tateishi J: Distinctive immunohistochemical profiles of small heat shock proteins (Heat Shock Protein 27 and aB-Crystallin) in human Brain Tumors. Cancer 77: 352-61, 1996.
14. Huot J, Roy G, Lambert H, Chretien P, Landry J: Increased survival after treatments with anticancer agents of chinese hamster cells expressing the human Mr 27,000 heat shock protein. Cancer Res 51: 5245-5252, 1991.
15. Jakob U, Gaestel M, Engel K, Buchner J: Small heat shock proteins are molecular chaperons. J Biol Chem 268(3): 1517-1520, 1993.
16. Kato M, Herz F, Kato S, Hirano A: Expression of stress-responsive (heat-shock) protein 27 in human brain tumors: an immunohistochemical study. Acta Neuropathol 83: 420-422, 1992.
17. Khalid H, Yasunaga A, Kishikawa M, Shibata S: Immunohistochemical expression of the estrogen receptor-related antigen (ER-D5) in human intracranial tumors. Cancer 75: 2571-8, 1995.
18. Kleihves P et al: Histological typing of tumours of the central nervous system. 29 Edition, WHO, Springer-Verlag, 1993.
19. Landry J, Chretien P, Lambert H, Hickey E, Weber LA: Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells. J Cell Biol 109: 7-15, 1989.
20. Love S, King RJB: A 27Kda heat shock protein has anomalous prognostic powers in early and advanced breast cancer. Br J Cancer 69: 743-748, 1994.
21. Ng H-K, Leung S-Y: The new WHO classification of CNS tumors: A selective review. Advances in Anatomic Pathology 2(3): 195-207, 1995.
22. Oesterreich S, Weng C-N, Qiu M, Hilsenbeck SG, Osborne CK, Fuqua SAW: The small heat shock protein HSP27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res 53: 4443-4448, 1993.
23. Pauli D, Tonka C-H, Tissieres A, Arrigo A-P: Tissue-specific expression of the heat shock protein HSP27 during Drosophila melanogaster development. J. Cell Biol 111: 817-828, 1990.
24. Pechan PM: Heat shock proteins and cell proliferation. FEBS Lett 280(1): 1-4, 1991.
25. Puy LA, Lo Castro G, Olcese JE, Lotfi HO, Brandi HR, Ciocca DR: Analysis of a 24-kilodalton (KD) protein in the human uterine cervix during abnormal growth. Cancer 64: 1067-1073, 1989.
26. Schlesinger MJ: Heat shock proteins. J Biol Chem 265: 12111-12114, 1990.
27. Seymour L, Bezwoda WR, Meyer K: Tumor factors predicting for prognosis in metastatic breast cancer. The presence of p24 predicts for response to treatment and duration of survival. Cancer 66: 2390-2394, 1990.
28. Seymour L, Bezwoda WR, Meyer K, Behr C: Detection of P24 protein in human breast cancer : influence of receptor status and oestrogen exposure. Br J Cancer 61: 886-890, 1989.
29. Smith DF: Steroid Receptors and Molecular chaperons. Scientific American, Science and Medicine, July/August, 1995.
30. Strahler JR, Kuick R, Eckerskorn C, Lottspeich F, Richardson BC, Fox DA, Stoolman LM, Hanson CA, Nichols D, Tueche HJ, Hanash SM: Identification of two related markers for common acute lymphoblastic leukemia as heat shock protein. J Clin Invest 85: 200-207, 1990.
31. Têtu B, Lacasse B, Bouchard H-L, Lagace R, Huot J, Landry J: Prognostic influence of HSP27 expression in malignant fibrous histiocytoma:a clinocopathological and immunohistochemical study. Cancer Res 52: 2325-2328, 1992.
32. Thomas SA, Brown IL, Hollins GW, Hocken A, Kirk D, King RJB, Leake RE: Detection and distribution of heat shock proteins 27 and 90 in human benign and malignant prostatic tissue. British Journal of Urology 77: 367-372, 1996.
33. Thor A, Benz C, Moore II D, Goldman E, Edgerton S, Landry J, Schwartz L, Mayall B, Hickey E, Weber LA: Stress responsive protein (srp-27) determination in primary human breast carcinomas: clinical, histologic and prognostic correlations. J Natl Cancer Inst 83: 170-178, 1991.
34. Ungar DR, Hailat N, Strahler JR, Kuick RD, Brodeur GM, Seeger RC, Reynolds P, Hanash SM- Hsp27 expression in neuroblastoma: correlation with disease stage J Natl Cancer Inst 86: 780-784, 1994.
35. Welch WJ: How cells respond to stress. Scientific American, May 34-41, 1993.
36. Yokoyama N, Iwaki T, Goldman JE, Tateishi J, Fukui M: Small heat shock protein is expressed in meningiomas and in granulofilamentous inclusion bodies. Acta Neuropathol Berl 85(3): 248-255, 1993.